Viewing StudyNCT00153023



Ignite Creation Date: 2024-05-05 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00153023
Status: COMPLETED
Last Update Posted: 2013-11-13
First Post: 2005-09-09

Brief Title: 1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy
Sponsor: Boehringer Ingelheim
Organization: Boehringer Ingelheim

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-04
Start Date Type: None
Primary Completion Date: 2005-12
Primary Completion Date Type: ACTUAL
Completion Date: 2005-12
Completion Date Type: None
First Submit Date: 2005-09-09
First Submit QC Date: September 9 2005
Study First Post Date: 2005-09-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-11-12
Last Update Post Date: 2013-11-13
Last Update Post Date Type: ESTIMATED